FRANKLIN LAKES, N.J. — A diabetes research organization and a medical technology company have extended their partnership.
The Juvenile Diabetes Research Foundation and medical supply manufacturer BD — which previously collaborated to enhance the use of insulin pumps in patients with Type 1 diabetes — said they will accelerate the development of BD's proprietary glucose-sensing technology, which has shown promise in providing very accurate and reliable continuous glucose information.
"BD understands and believes in JDRF's commitment to and excitement about the prospects of developing better technologies in a relatively short timeframe to benefit people with diabetes," JDRF president and CEO Jeffrey Brewer said. "BD is well positioned to address the patient need given its heritage in injection- and infusion-based drug delivery. We look forward to working with BD on this initiative."